Literature DB >> 22286022

The vasohibin family: Novel regulators of angiogenesis.

Yasufumi Sato1.   

Abstract

Angiogenesis is thought to be regulated by the local balance between angiogenesis stimulators and angiogenesis inhibitors. A number of endogenous regulators of angiogenesis have been found in the body. We recently isolated vasohibin-1 (VASH1) as a negative feedback regulator of angiogenesis produced by endothelial cells, and VASH2 as a homologue of VASH1 thereafter. We found that VASH1 was expressed in endothelial cells to terminate angiogenesis, whereas VASH2 promoted angiogenesis, in the mouse model of angiogenesis. This mini-review will focus on the vasohibin family in relation to the regulation of angiogenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286022     DOI: 10.1016/j.vph.2012.01.002

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  10 in total

1.  Vasohibin1, a new mouse cardiomyocyte IRES trans-acting factor that regulates translation in early hypoxia.

Authors:  Fransky Hantelys; Anne-Claire Godet; Florian David; Florence Tatin; Edith Renaud-Gabardos; Françoise Pujol; Leila H Diallo; Isabelle Ader; Laetitia Ligat; Anthony K Henras; Yasufumi Sato; Angelo Parini; Eric Lacazette; Barbara Garmy-Susini; Anne-Catherine Prats
Journal:  Elife       Date:  2019-12-09       Impact factor: 8.140

Review 2.  Novel targets against retinal angiogenesis in diabetic retinopathy.

Authors:  Shuang Wang; James K Park; Elia J Duh
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

3.  Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.

Authors:  Tao Zhang; Ting-Ting Yu; Dong-Ming Zhang; Xiao-Ming Hou; Xiao-Jun Liu; Da Zhao; Li Shan
Journal:  Med Oncol       Date:  2014-04-20       Impact factor: 3.064

4.  C1q as a unique player in angiogenesis with therapeutic implication in wound healing.

Authors:  Fleur Bossi; Claudio Tripodo; Lucia Rizzi; Roberta Bulla; Chiara Agostinis; Carla Guarnotta; Carine Munaut; Gustavo Baldassarre; Giovanni Papa; Sonia Zorzet; Berhane Ghebrehiwet; Guang Sheng Ling; Marina Botto; Francesco Tedesco
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

5.  Expression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus.

Authors:  Yamato Ninomiya; Soji Ozawa; Junya Oguma; Akihito Kazuno; Miho Nitta; Hiroshi Kajiwara; Yasufumi Sato
Journal:  Oncol Lett       Date:  2018-08-01       Impact factor: 2.967

6.  Vasohibin-1 suppresses colon cancer.

Authors:  Shuai Liu; Bing Han; Qunyuan Zhang; Jie Dou; Fang Wang; Wenli Lin; Yuping Sun; Guangyong Peng
Journal:  Oncotarget       Date:  2015-04-10

7.  Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.

Authors:  Shuji Kitahara; Yasuhiro Suzuki; Masae Morishima; Asuka Yoshii; Sachiko Kikuta; Kazuhiko Shimizu; Shunichi Morikawa; Yasufumi Sato; Taichi Ezaki
Journal:  Mol Cancer       Date:  2014-05-04       Impact factor: 27.401

8.  Assessment of the Concentration of Endogenous Factors Regulating Angiogenesis, VASH-1 and VEGF-A, in the Blood Serum of Patients with Neuroendocrine Neoplasms.

Authors:  Janusz Strzelczyk; Monika Wójcik-Giertuga; Piotr Cuber; Krzysztof Biernacki; Beata Kos-Kudła; Joanna Katarzyna Strzelczyk
Journal:  Biomed Res Int       Date:  2022-03-10       Impact factor: 3.411

9.  The prognostic significance of vasohibin-1 expression in patients with prostate cancer.

Authors:  T Kosaka; Y Miyazaki; A Miyajima; S Mikami; Y Hayashi; N Tanaka; H Nagata; E Kikuchi; K Nakagawa; Y Okada; Y Sato; M Oya
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640

10.  PMA inhibits endothelial cell migration through activating the PKC-δ/Syk/NF-κB-mediated up-regulation of Thy-1.

Authors:  Heng-Ching Wen; Yen Nien Huo; Chih-Ming Chou; Wen-Sen Lee
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.